The purpose of this study is to determine if Continuous glucose monitoring improves glycemic control and pregnancy outcomes of Gestational Diabetes Mellitus
Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance that is first identified during pregnancy, excluding diabetic patients diagnosed before pregnancy. The purpose of this study is to determine if Continuous glucose monitoring improves glycemic control and pregnancy outcomes of Gestational Diabetes Mellitus.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
154
Patients in the intervention group will receive Continuous Glucose Monitoring(CGMS) every 4 weeks since diagnosed with GDM，and the control grouponly once receive CGMS during the last month and have management adjusted based on the CGMS readings Other Name: iPro, Medtronic
Shanghai First People's Hospital, Shanghai Jiao Tong University 100 Haining Road,Shanghai
Shanghai, Shanghai Municipality, China
RECRUITINGtime in range at Week 8 after enrollment
time in range of CGMS at Week 8 after enrollment
Time frame: at Week 8 after enrollment
the level of HbA1c before delivery
the level of HbA1c before delivery in two groups
Time frame: 37 weeks of gestation
the incidence of hypoglycemic events
the incidence of hypoglycemic events (blood glucose \<3.3mmol/L, with or without hypoglycemic symptoms) during the follow-up period of patients in the two groups
Time frame: 14 weeks
adverse pregnancy outcomes
adverse pregnancy outcomes (preterm, macrosomia, greater than gestational age, less than gestational age, compound end point (birth injury, neonatal hypoglycemia, hyperbilirubinemia, apgar score \< 7 within 5 minutes of birth, neonatal phototherapy, neonatal respiratory distress syndrome
Time frame: 3 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.